Fosinopril sodium

This classification denotes an ace inhibitor with the molecular formula C30H45NO7P.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NW2RTH6T2N, chemically known as l-proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, sodium salt, (1(s*(r*)),2alpha,4beta)- but more generally known as fosinopril sodium, which bears US NIH Compound Identifier 55890. European Medicines Agency schedules Fosinopril sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02265MIG. Most nations, for tariff and trade purposes, schedule fosinopril sodium under HS 29339990 and SITC 51577. As of Q4 2014, FOSINOPRIL SODIUM remains US FDA's Preferred Term for this commodity. Fosinopril sodium bears US NLM identifiers UMLS ID C0733440 and NCI Concept Code C47542. SMILES: CCC(=O)O[C@H](C(C)C)O[P@@](=O)(CCCCC1CCCCC1)CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3.[NA+].